Anavex Life Sciences Corp (NASDAQ:AVXL)

10.90
Delayed Data
As of Oct 04
 +0.40 / +3.81%
Today’s Change
7.13
Today|||52-Week Range
23.73
-37.14%
Year-to-Date

Today’s Trading

Previous close10.49
Today’s open10.68
Day’s range10.46 - 10.90
Volume872,662
Average volume (3 months)859,038
Market cap$804.4M
Data as of 3:59pm ET, 10/04/2022

Growth & Valuation

Earnings growth (last year)-20.26%
Earnings growth (this year)-13.58%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book5.19

Competitors

 Today’s
change
Today’s
% change
ADPTAdaptive Biotechnolo...+0.94+12.97%
NOTVInotiv Inc+1.86+10.48%
AMRNAmarin Corporation P...+0.09+8.04%
FGENFibroGen Inc+0.50+3.77%
Data as of 4:00pm ET, 10/04/2022

Financials

Next reporting dateDecember 12, 2022
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$0.00
Annual profit (last year)-$37.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
New York, New York

Forecasts